Market Expansion LUMEDX is expanding from cardiovascular data intelligence to analytics for orthopedics, neurology, spine, and maternal/fetal medicine, presenting cross-sell opportunities to hospitals with multi-specialty needs and data integration requirements.

Enterprise Footprint Serving over 650 hospitals with an end-to-end software and services suite positions LUMEDX as a trusted analytics partner; target large health systems and IDNs that require embedded analytics at the point of care and seamless EHR data integration.

Acquisition Context LUMEDX was acquired by Intelerad in early 2021, suggesting potential alignment with broader enterprise imaging workflows and cross-sell opportunities into Intelerad’s customer base and product ecosystem.

Financial Scale With reported revenue in the 50–100 million range and a mid-size employee base, there is room for upsell of premium analytics modules, expanded services, and managed analytics offerings to grow average contract value.

Tech & Data Existing tech stack and emphasis on embedded analytics at the point of care indicate opportunities to propose advanced data integration, cloud-based analytics enhancements, and AI-driven insights for multiple specialties.